Perceptions of Generic Drugs in the Pharmacists of Public Hospitals: A Cross-sectional Survey in Hubei Province of China

Li, Weijie; Xia, Mengna; Gong, Shiwei; Ding, Yong

doi:10.1007/s11596-021-2412-4

Cited by 3 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…( 9 ). Unfortunately, the quality of generic drugs is not high, and we doubt that generic drugs in the Chinese market will be able to replace the original drugs in the real world ( 10 , 11 ), or if patients have an inflexible demand for brand-name drugs, which may lead to higher prices for the same after patent expiration, offsetting loss of profit margin from the market ( 12 ). On the other hand, although there are 2,210 ANDA applications for generic drug registration in China in 2021, representing a 81.30% increase over the previous year ( 13 ).…”

Section: Introductionmentioning

confidence: 99%

An empirical study of the impact of generic drug competition on drug market prices in China

Yina,

Pengcheng,

Haomiao

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

IntroductionGeneric substitution is encouraged to reduce pharmaceutical spending in China, and with incentive policies, the market size of the generic drug continues to rise. To find out how the generic competition affects drug price in this area, this study examines how the quantity of generic drug manufacturers can influence average drug price in the Chinese market.MethodsThis study uses a rigorous selection of drugs from the 2021 China’s National Reimbursement Drug List (NRDL), and uses drug-level fixed effects regressions to estimate the relationship between competition and price within each drug.ResultsWe note that drug prices decline with increasing competition in the Chinese market, but not in a perfectly linear manner, with marginal price declines decreasing after the fourth entrant and “rebounding” at subsequent entrants, especially the sixth.DiscussionThe findings suggest the importance of maintaining effective competition between suppliers to control prices, and that the government needs to further control generic pricing, especially for late entry generics, to ensure effective competition in the Chinese market.

show abstract